top of page

Jun 24 2025. Selected for the National New Drug Development Project.

  • leelabsup
  • 7월 2일
  • 1분 분량

The project to develop a treatment for alcoholic liver disease using a ZBP1 inhibitor has been selected for support by the Korea Drug Development Fund (KDDF).

Originally noted for its ability to control cytokine storms in COVID-19, the ZBP1 inhibitor is now expected to gain momentum as a potential treatment for alcoholic liver disease.


06.24.2025 Press release : https://news.unist.ac.kr/kor/20250624-2/




 
 
 

Comments


Copyright © 2022 Viral Immunology Lab of UNIST

bottom of page